The COVID-19 situation in the US is continuing to improve, as the nation records declining case numbers in all 50 states

It comes as the Biden administration announces that the country will share an additional 20 million doses of COVID-19 vaccines with the world by the end of June.

This announcement follows the White House previously allocating 60 million doses of the AstraZeneca vaccine.

The vaccines will be a combination of Moderna, Pfizer and Johnson & Johnson

This will come after the Food and Drug Administration give the vaccine a stamp of approval.

However, there is no word yet on when AstraZeneca will receive the required authorisation.

Biden says he knows America will “never be fully safe until the pandemic that’s raging globally is under control”.

Biden also said he plans on moving America towards becoming an “arsenal” of global vaccine supply.

Concerns over COVID-19 vaccine patents

This comes after the US announced it supports waving Covid-19 vaccine patents.

Many countries have voiced strong opposition to the proposal, including Germany.

Germany’s government says “the protection of intellectual property is a source of innovation and must remain so”.

However, the European Union has expressed its readiness to consider the proposal, with a number of other member states throwing their support behind the initiative.